
1001 - 5000 employees
Founded 2014
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $857.5M Post-IPO Equity on 2021-04
Healthcare • Biotechnology • Pharmaceuticals
Zai Lab is an innovative, research-based, commercial stage biopharmaceutical company based in China and the U. S. focused on bringing transformative medicines for oncology, immunology, neuroscience, and infectious diseases to patients in China and around the world. Their mission is to provide innovative treatments to patients with unmet medical needs, significantly impacting global health.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 September 15
Associate Director guiding clinical regulatory strategy, IND submissions, and health authority interactions for Zai Lab’s global biopharmaceutical programs. Coordinating regulatory execution across cross-functional development teams.
🏄 California – Remote
💵 $180k - $241k / year
💰 $857.5M Post-IPO Equity on 2021-04
⏰ Full Time
🟠 Senior
🚔 Compliance
👻 Ghost score 0%
🕒 August 25
Senior Director leading global CMC regulatory strategy for Zai Lab’s small-molecule and biologic therapies. Managing submissions, health-authority interactions, regulatory risk, and CMC professionals.
🏄 California – Remote
💵 $258k - $320k / year
💰 $857.5M Post-IPO Equity on 2021-04
⏰ Full Time
🟠 Senior
🚔 Compliance
👻 Ghost score 7%
🗣️🇨🇳 Chinese Required